Significant differences in the degradation of pro-leu-gly-nH2 by human serum and that of other species (38484).
The acyclic C-terminal tripeptide of oxytocin, H-Pro-Leu-Gly-NH-2, is not degraded upon incubation with human (male,female or pregnant female) plasma or serum for 1hr at 37 degrees. However, the sera of other species tested, including rat, chicken and carp, degrade this tripeptide 100%, 4% and 30%, respectively, in 1 hr, as determined by quantitative amino acid analysis of released products. Among the species studied there seems to exist a correlation between the anatomic development of the pars intermedia and the ability of the serum to hydrolyze H-Pro-Leu-Gly-NH-2, which has been proposed to be a MSH-release-inhibiting factor. The only identified degradation products are Pro, Leu and H-Gly-NH-2 with no detectable levels of H-Leu-Gly-NH2. The dipeptides H-Leu-Gly-NH-2 and H-Pro-Leu-OH are each cleaved at similiar rates in either human or rat serum, although the rate of hydrolysis of both peptides is lower in human than in rat. Thus, it does not appear that the dipeptide, H-EU-Gly-NH-2, can accumulate as one of the breakdown products of the tripeptide. The arylamidase present in rat serum has different characteristics from the enzyme in rat brain which can degrade H-Pro-Leu-Gly-NH-2.
D000626:Aminopeptidases / Q000097:blood / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000201:enzymology; D002347:Carps; D002645:Chickens; D005260:Female; D005998:Glycine / Q000032:analysis; D006801:Humans; D006868:Hydrolysis; D007930:Leucine / Q000032:analysis; D008297:Male; D009842:Oligopeptides / Q000097:blood*; D010121:Oxytocin / Q000378:metabolism; D010446:Peptide Fragments / Q000032:analysis; D010447:Peptide Hydrolases / Q000097:blood; D011247:Pregnancy; D011392:Proline / Q000032:analysis; D051381:Rats
D009842:Oligopeptides; D010446:Peptide Fragments; D010121:Oxytocin; D011392:Proline; D010447:Peptide Hydrolases; D000626:Aminopeptidases; D007930:Leucine; D005998:Glycine